| P50 | author | Jarrod R Fortwendel | Q43089774 |
| | William J Steinbach | Q89583459 |
| | Praveen R Juvvadi | Q95970423 |
| P2093 | author name string | Luise E Rogg | |
| P2860 | cites work | Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis | Q28217179 |
| | Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America | Q28263689 |
| | Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation | Q29620223 |
| | Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America | Q33894472 |
| | Calcineurin: a calcium- and calmodulin-binding protein of the nervous system | Q33986891 |
| | The iron chelator deferasirox enhances liposomal amphotericin B efficacy in treating murine invasive pulmonary aspergillosis | Q33988576 |
| | Rationale for combination antifungal therapy | Q34335236 |
| | Hsp90 potentiates the rapid evolution of new traits: drug resistance in diverse fungi | Q34455495 |
| | Calcineurin controls growth, morphology, and pathogenicity in Aspergillus fumigatus | Q34718619 |
| | Good fungi gone bad: the corruption of calcineurin | Q34906798 |
| | Calcineurin target CrzA regulates conidial germination, hyphal growth, and pathogenesis of Aspergillus fumigatus | Q36747015 |
| | Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections | Q36823712 |
| | Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease | Q37115266 |
| | Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis | Q39652561 |
| | In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp. | Q39652771 |
| | Transcriptional regulation of chitin synthases by calcineurin controls paradoxical growth of Aspergillus fumigatus in response to caspofungin | Q39895162 |
| | A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal Meningitis | Q41644134 |
| | Efficacy of caspofungin and voriconazole combinations in experimental aspergillosis. | Q42286250 |
| | Calcineurin inhibition or mutation enhances cell wall inhibitors against Aspergillus fumigatus | Q42433042 |
| | Differential effects of inhibiting chitin and 1,3-{beta}-D-glucan synthesis in ras and calcineurin mutants of Aspergillus fumigatus | Q43194334 |
| | Combination of caspofungin with inhibitors of the calcineurin pathway attenuates growth in vitro in Aspergillus species | Q44299876 |
| | Combination antifungal therapy for invasive aspergillosis | Q45096994 |
| | Combination therapy for invasive aspergillosis | Q45096996 |
| | Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies: a randomized pilot study (Combistrat trial). | Q46946844 |
| | Trends in Risk Profiles for and Mortality Associated with Invasive Aspergillosis among Liver Transplant Recipients | Q57569380 |
| | Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids | Q68926740 |
| P921 | main subject | aspergillosis | Q259626 |
| P304 | page(s) | S77-81 | |
| P577 | publication date | 2010-07-07 | |
| P1433 | published in | Medical Mycology | Q6806389 |
| P1476 | title | Newer combination antifungal therapies for invasive aspergillosis | |
| P478 | volume | 49 Suppl 1 | |